During Q4 2018 the big money sentiment decreased to 0.96. That’s change of 0.23, from 2018Q3’s 1.19. 51 investors sold all, 125 reduced holdings as INCY ratio is negative. 117 rose holdings while 52 funds amassed holdings. Funds hold 188.24 million shares thus 4.06% more from 2018Q3’s 180.88 million shares. Geode Cap Mgmt Llc reported 2.36 million shs or 0.05% of all its holdings. Tiaa Cref Invest owns 330,297 shs for 0.02% of their capital. 7,734 were accumulated by Envestnet Asset Management. Livforsakringsbolaget Skandia Omsesidigt stated it has 0.02% of its capital in Incyte Corporation (NASDAQ:INCY). 9,000 were accumulated by Nj State Employees Deferred Compensation Plan. Georgia-based Voya Mgmt Llc has invested 0.02% in Incyte Corporation (NASDAQ:INCY). Victory Management Inc invested in 2,602 shs or 0% of the stock. Walleye Trading Ltd Liability Co reported 0% stake. Blume Management Inc holds 100 shs or 0% of its capital. Sands Management Limited Liability Company stated it has 4.36M shs. 9,226 were accumulated by Boothbay Fund Management Lc. Pillar Pacific Mgmt Ltd holds 0.1% in Incyte Corporation (NASDAQ:INCY) or 11,690 shs. State Of Alaska Department Of Revenue reported 32,101 shs stake. Kistler invested in 340 shs or 0.01% of the stock. Farmers And Merchants Invests Inc holds 0% of its capital in Incyte Corporation (NASDAQ:INCY) for 66 shs.

INCY registered $7.51 million net activity with 1 insider purchase and 10 selling transactions since October 3, 2018. 10,000 shs were sold by SWAIN PAULA J, worth $700,000. Trower Paul sold $435,975 worth of stock or 5,813 shs. Wenqing Yao sold $750,000 worth of stock. $68,765 worth of stock was bought by BIENAIME JEAN JACQUES on Thursday, November 8.

The stake In Incyte Corp (INCY) was reduced held by Matrix Capital Management Company Lp. According to 2018Q4 SEC filling the reduction is 13%. 600,000 shares were sold by Matrix Capital Management Company Lp as the company’s stock rose 29.88% with the market. The hedge fund is holding 4.02 million shares, compared to the 4.62 million from the previous quarter. And the reported value of the commercial physical & biological resarch company is $255.43M for the 2018Q4. $18.17 billion is the MC of Incyte Corp. Ticker’s shares touched $84.9 during the last trading session after 0.87% change.Currently Incyte Corporation is uptrending after 2.79% change in last March 13, 2018. INCY has 758,464 shares volume. INCY underperformed the S&P500 by 1.58%.

Matrix Capital Management Company Lp has risen its stake in Tableau Software Inc (NYSE:DATA) and also increased its holding in Adaptimmune Therapeutics Plc by 6.79 million shares in the quarter, for a total of 27.15M shares.

On May, 7 is anticipated Incyte Corporation (NASDAQ:INCY)’s earnings report, as reported by Faxor. Analysts have anticipation on stock’s earnings per share of $0.23. That’s up 227.78 % from last year?s $-0.18 earnings per share. If earnings per share of $0.23 is reported the profit of INCY could be $49.23M giving it 92.28 P/E. -34.29 % negative EPS growth is what analysts predict. $0.35 earnings per share was reported for last quarter.

For more Incyte Corporation (NASDAQ:INCY) news released recently go to: Seekingalpha.com, Nasdaq.com, Gurufocus.com, Nasdaq.com or Seekingalpha.com. The titles are as follows: “Incyte Corporation (INCY) CEO Hervé Hoppenot on Q4 2018 Results – Earnings Call Transcript – Seeking Alpha” released on February 14, 2019, “Is a Disappointment in Store for Incyte (INCY) Q4 Earnings? – Nasdaq” on February 11, 2019, “New Research Coverage Highlights Nasdaq, Constellation Brands, Incyte, IMAX, HNI, and Frank’s International NV — Consolidated Revenues, Company Growth, and Expectations for 2019 – GuruFocus.com” with a publish date: March 01, 2019, “Nasdaq 100 Movers: FB, INCY – Nasdaq” and the last “Incyte Q4 top line up 25% – Seeking Alpha” with publication date: February 14, 2019.

Incyte Corporation (NASDAQ:INCY) Ratings Coverage

A total of 10 analysts rate Incyte (NASDAQ:INCY) as follows: 5 “Buy”, 5 “Hold” and 0 “Sell”. ?herefore 50% are bullish. The firm has $100 highest and $73 lowest target. The avg target $85.33 is 0.51% above the last ($84.9) price. (NASDAQ:INCY) has 13 ratings reports on Mar 13, 2019 according to StockzIntelligence. On Wednesday, January 16 the firm has “Neutral” rating given by UBS. On Thursday, February 14 the firm earned “Buy” rating by Piper Jaffray. On Monday, February 25 the company was maintained by Argus Research. On Thursday, January 3 Guggenheim upgraded Incyte Corporation (NASDAQ:INCY) to “Buy” rating. On Monday, October 22 the company was maintained by Cantor Fitzgerald. On Thursday, January 24 William Blair upgraded Incyte Corporation (NASDAQ:INCY) to “Outperform” rating. On Thursday, February 14 the stock of Incyte Corporation (NASDAQ:INCY) earned “Hold” rating by Oppenheimer. On Thursday, January 24 the firm has “Buy” rating given by Gabelli. On Thursday, February 14 Cantor Fitzgerald maintained Incyte Corporation (NASDAQ:INCY) with “Hold” rating.